193 related articles for article (PubMed ID: 18391792)
21. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
Marsboom G; Janssens S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
[TBL] [Abstract][Full Text] [Related]
22. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
23. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease.
Broekhuizen LN; Mooij HL; Kastelein JJ; Stroes ES; Vink H; Nieuwdorp M
Curr Opin Lipidol; 2009 Feb; 20(1):57-62. PubMed ID: 19106708
[TBL] [Abstract][Full Text] [Related]
24. [The role of endothelial progenitor cells in renal disease].
Lazzeri E; Angelotti ML; Ballerini L; Becherucci F; Mazzinghi B; Parente E; Ronconi E; Sagrinati C; Romagnani P; Lasagni L
G Ital Nefrol; 2008; 25(5):537-46. PubMed ID: 18828116
[TBL] [Abstract][Full Text] [Related]
25. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
26. Endothelial activation, dysfunction and permeability during severe infections.
Lee WL; Liles WC
Curr Opin Hematol; 2011 May; 18(3):191-6. PubMed ID: 21423012
[TBL] [Abstract][Full Text] [Related]
27. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
28. A potential role for CD8+ T-cells as regulators of CNS vascular permeability.
Suidan GL; Pirko I; Johnson AJ
Neurol Res; 2006 Apr; 28(3):250-5. PubMed ID: 16687049
[TBL] [Abstract][Full Text] [Related]
29. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factors in cardiovascular medicine.
Testa U; Pannitteri G; Condorelli GL
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1190-221. PubMed ID: 19001927
[TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo.
Fürst R; Bubik MF; Bihari P; Mayer BA; Khandoga AG; Hoffmann F; Rehberg M; Krombach F; Zahler S; Vollmar AM
Mol Pharmacol; 2008 Jul; 74(1):1-8. PubMed ID: 18413663
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
[TBL] [Abstract][Full Text] [Related]
33. Small GTPases in mechanosensitive regulation of endothelial barrier.
Birukov KG
Microvasc Res; 2009 Jan; 77(1):46-52. PubMed ID: 18938185
[TBL] [Abstract][Full Text] [Related]
34. Circulating endothelial progenitor cells in cardiovascular disorders.
Geft D; Schwartzenberg S; George J
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1115-21. PubMed ID: 18793114
[TBL] [Abstract][Full Text] [Related]
35. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies.
Claesson-Welsh L; Dejana E; McDonald DM
Trends Mol Med; 2021 Apr; 27(4):314-331. PubMed ID: 33309601
[TBL] [Abstract][Full Text] [Related]
36. Methods to assess tissue permeability.
Ibla JC; Khoury J
Methods Mol Biol; 2013; 1066():81-8. PubMed ID: 23955735
[TBL] [Abstract][Full Text] [Related]
37. Vascular permeability--the essentials.
Claesson-Welsh L
Ups J Med Sci; 2015; 120(3):135-43. PubMed ID: 26220421
[TBL] [Abstract][Full Text] [Related]
38. Keynote review: epithelial and endothelial barriers in human disease.
Mullin JM; Agostino N; Rendon-Huerta E; Thornton JJ
Drug Discov Today; 2005 Mar; 10(6):395-408. PubMed ID: 15808819
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.
Doucet A; Favre G; Deschênes G
Pediatr Nephrol; 2007 Dec; 22(12):1983-90. PubMed ID: 17554565
[TBL] [Abstract][Full Text] [Related]
40. Permeability of technical and biological tissues.
Franke RP; Fuhrmann R; Hiebl B; Mrowietz C; Jung F
Clin Hemorheol Microcirc; 2009; 43(1-2):149-55. PubMed ID: 19713609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
